Rylees Boy Gets Positive in 2011 RP Championship

Rylees Boy has medication positive in 2011 Remington Park Championship.

Q-Racing Journal
December 12, 2012

Generic Racing Photo

Remington Park stewards disqualified Rylees Boy from his win in the May 28, 2011, Remington Park Invitational Championship (G1) at Remington Park due to a medication positive. The decision came at an October 31, 2012, meeting of the board of stewards at Remington Park at an Oklahoma State Racing Commission meeting. The case is currently under appeal, so the results of the race, his race record and awards will not be affected until the decision is made final.

The hearing for the case was rescheduled nine times since the original hearing date of September 21, 2011.

Rylees Boy was owned and trained by Gerardo Ochoa-Pena at the time of the race.

The positive test was for an overage of Fluphenazine, a long-acting tranquilizer and a Class 2 medication. According to the RCI, a Class 2 medication has a high potential to affect performance, but less of a potential than drugs in Class 1. These drugs are not generally accepted as therapeutic agents in racing horses or they are therapeutic agents that have a high potential for abuse. Drugs in this class include: psychotropic drugs, certain nervous system and cardiovascular system stimulants, depressants, and neuromuscular blocking agents.

The Board of Stewards handed Ochoa-Pena a one year suspension and $2,500 fine.

If Rylees Boy’s disqualification from the $250,000 Remington Park Invitational Championship is upheld, the order of finish would be: Louisiana Senator, Streakin Down, Freaky, Stolis Winner, Noconi, Favorite Cartel, Fishin CR, Diamond For Jess, Feature Jess Rockin, Mr Truly Uno and The Louisiana Cartel.

Rylees Boy, who was the 2011 champion aged gelding, currently has a record of 20 wins in 42 starts, with nine second-place finishes and five thirds. He has earnings of $946,166.

The 7-year-old gelding is currently owned by Lorena Velazquez Rodriguez and trained by champion trainer Paul Jones.